Australia (AU)

Reconstituting NK Cells After Allogeneic Stem Cell Transplantation Show Impaired Response to the Fungal Pathogen Aspergillus fumigatus (2020) Weiss E, Schlegel J, Terpitz U, Weber M, Linde J, Schmitt AL, Huenniger K, et al. Journal article Effects of nintedanib in patients with SSc-ILD and preserved and highly impaired lung function (2020) Wuyts WA, Azuma A, Distler J, Sondergaard K, Proudman S, Cottin V, Erhardt E, et al. Conference contribution Protein Component of Oyster Glycogen Nanoparticles: An Anchor Point for Functionalization (2020) Besford QA, Weiss ACG, Schubert J, Ryan TM, Maitz MF, Tomanin PP, Savioli M, et al. Journal article Consensus statement on the problem of terminology in psychological interventions using the internet or digital components (2020) Smoktunowicz E, Barak A, Andersson G, Banos RM, Berger T, Botella C, Dear BF, et al. Journal article Induced Photon Correlations Through the Overlap of Two Four-Wave Mixing Processes in Integrated Cavities (2020) Zhang Y, Kues M, Roztocki P, Reimer C, Fischer B, Maclellan B, Bisianov A, et al. Journal article Chalcogenide fibers for kerr squeezing (2020) Anashkina EA, Andrianov A, Corney JF, Leuchs G Journal article Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study (2020) Dimopoulos MA, Lonial S, White D, Moreau P, Weisel K, San-Miguel J, Shpilberg O, et al. Journal article CROSSED PRODUCTS OF C*-ALGEBRAS FOR SINGULAR ACTIONS WITH SPECTRUM CONDITIONS (2020) Grundling H, Neeb KH Journal article Characteristics of the first 615 patients enrolled in Pacific R: A study of the first real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy (2020) Girard N, Fietkau R, Garassino M, Garrido P, Field JK, Peters S, Smit HJM, et al. Conference contribution EPIK-B3: A phase III, randomised, double-blind (DB), placebo (PBO)-controlled study of alpelisib (ALP) plus nab-paclitaxel (nabPTX) in advanced triple-negative breast cancer (TNBC) with either PIK3CA mutation or phosphatase and tensin homolog (PTEN) loss without PIK3CA mutation (2020) Sharma P, Farooki A, Fasching P, Loi S, Peterson K, Prat A, Tripathy D, et al. Conference contribution